This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jul 28;292(4):499-500.

doi: 10.1001/jama.292.4.499.

Can current treatments for advanced non-small-cell lung cancer be improved?

Athanassios Argiris, Joan H Schiller

PMID: 15280349
DOI: 10.1001/jama.292.4.499

Comment

Can current treatments for advanced non-small-cell lung cancer be improved?

Athanassios Argiris et al. JAMA. 2004.

. 2004 Jul 28;292(4):499-500.

doi: 10.1001/jama.292.4.499.

Authors

Athanassios Argiris, Joan H Schiller

PMID: 15280349
DOI: 10.1001/jama.292.4.499

No abstract available

PubMed Disclaimer

Comment on

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.
Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. JAMA. 2004 Jul 28;292(4):470-84. doi: 10.1001/jama.292.4.470. JAMA. 2004. PMID: 15280345

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information